AU5287599A - Use of hc gp-39 in immune diseases - Google Patents

Use of hc gp-39 in immune diseases

Info

Publication number
AU5287599A
AU5287599A AU52875/99A AU5287599A AU5287599A AU 5287599 A AU5287599 A AU 5287599A AU 52875/99 A AU52875/99 A AU 52875/99A AU 5287599 A AU5287599 A AU 5287599A AU 5287599 A AU5287599 A AU 5287599A
Authority
AU
Australia
Prior art keywords
immune diseases
immune
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52875/99A
Other languages
English (en)
Inventor
Anna Maria Helena Boots
Andreas Martinus Maria Miltenburg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU5287599A publication Critical patent/AU5287599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU52875/99A 1998-07-23 1999-07-19 Use of hc gp-39 in immune diseases Abandoned AU5287599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98202471 1998-07-23
EP98202471 1998-07-23
PCT/EP1999/005331 WO2000004917A2 (en) 1998-07-23 1999-07-19 USE OF HC gp-39 IN IMMUNE DISEASES

Publications (1)

Publication Number Publication Date
AU5287599A true AU5287599A (en) 2000-02-14

Family

ID=8233962

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52875/99A Abandoned AU5287599A (en) 1998-07-23 1999-07-19 Use of hc gp-39 in immune diseases

Country Status (4)

Country Link
EP (1) EP1100526A2 (ja)
JP (1) JP2002521344A (ja)
AU (1) AU5287599A (ja)
WO (1) WO2000004917A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04000769A (es) 2001-07-24 2005-09-21 Zhu Zhou Metodos, composiciones y equipos relacionados a quitinasas y moleculas similares a la quitinasa y enfermedad inflamatoria.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
US5843449A (en) * 1996-03-25 1998-12-01 Akzo Nobel N.V. Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
EP0805206A3 (en) * 1996-05-03 1999-09-15 Smithkline Beecham Corporation Human cartilage glycoprotein
US5811535A (en) * 1996-08-09 1998-09-22 Smithkline Beecham Corporation Human cartilege gp39-like gene

Also Published As

Publication number Publication date
WO2000004917A3 (en) 2000-07-20
WO2000004917A9 (en) 2000-08-24
WO2000004917A2 (en) 2000-02-03
EP1100526A2 (en) 2001-05-23
JP2002521344A (ja) 2002-07-16

Similar Documents

Publication Publication Date Title
IL108973A0 (en) Non-soiling cutlery
ZA954983B (en) N-terminally extended proteins expressed in yeast
AU1616499A (en) Chemokine variants and methods of use
AU3068699A (en) Skin equivalent and methods of forming and using same
AU3159499A (en) Antigen preparation and use
AU3167499A (en) Human body cleaner
AU1945395A (en) Use of xylanase in baking
AU7269094A (en) Improvements in or relating to playthings
AU1914400A (en) Human hydrolase proteins
AU3634595A (en) Bis-oxazolidines and their use
AU9017598A (en) Human frezzled-like protein
AU7965398A (en) Methods and solutions for cleaning dentures
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
AU5287599A (en) Use of hc gp-39 in immune diseases
IL118404A0 (en) Enzyme degrading rhamnogalacturonane II its preparation and use
GB9807586D0 (en) Enzymes and their use
AU4992099A (en) Human presenilin-associated protein
AU2593199A (en) Human smn-like protein
AU1664299A (en) Autodegradable microcarriers and their use
AU6782894A (en) Human dnase
AU3838695A (en) Use of the bio-spectrum in animal embryo-engineering
AU1289695A (en) Human stanniocalcin-alpha
AU7583998A (en) Human chemokine zchemo-8

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase